MedPath

Finding suitable clinical endpoints for ARID1B-related intellectual disability

Completed
Conditions
Coffin-Siris syndrom
intellectual disability
10057167
Registration Number
NL-OMON48746
Lead Sponsor
Centre for Human Drug Research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
24
Inclusion Criteria

ARID1B group
- Informed consent provided by both parents or the legal guardian prior to any study-mandated procedure.
- Known mutation in ARID1B.
- Assent provided by the participant.
Healthy control subjects
- Informed consent provided by both parents or the legal guardian if aged 11 years or younger.
- Informed consent provided by both parents or the legal guardian, and the participant if aged 12 up and till 15 years.
- Informed consent provided by the participant if aged 16 years or older.

Exclusion Criteria

Clear indication of not wanting to participate during the study
Use of drugs, benzodiazepines or any other medication or drug with the potential to influence study related endpoints in the investigator*s opinion.;Healthy control subjects:
- Presence of intellectual disability.

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>CNS tests, CHDR<br /><br>All subjects:<br /><br>- Saccadic eye movements<br /><br>- Body sway<br /><br>- Resting state electroencephalography<br /><br>- Task based EEG<br /><br>Visual evoked potential<br /><br>Auditory steady state response<br /><br>Passive auditory mismatch negativity<br /><br><br /><br>Group 2-4 (Subjects > age 4)<br /><br>- Adaptive tracking<br /><br>- Finger tapping<br /><br>- Smooth pursuit eye movement<br /><br>- Task based EEG<br /><br>Active auditory mismatch negativity<br /><br>- Memory tests<br /><br>Animal fluency test<br /><br>Stroop-like day-night test<br /><br><br /><br>Wearables, trial@home<br /><br>All subjects:<br /><br>- 6-day physical activity, heart rate, sleep (Nokia Steel HR)<br /><br>- 6-day questionnaire</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>not applicable</p><br>
© Copyright 2025. All Rights Reserved by MedPath